Integration with IRB Review and CTO Activities – Oversight Approval Required PRIOR to IRB Review and CTO Action
Download Intake Form Here
Integration with IRB Review and CTO Activities – Oversight Approval Required PRIOR to IRB Review and CTO Action
Download Intake Form Here
STAT Madness: Vote for the Brigham
The Brigham is among the contenders competing in STAT Madness 2020 — a bracketed competition from STAT News to find the most innovative research in the country. The first of six rounds of popular voting in the single-elimination ends March 8 at 11:59 p.m. EST. Vote now: https://www.statnews.com/feature/stat-madness/bracket/
Calling all members of the research community!
The Brigham Research Institute (BRI) would like to hear what topics are of interest to the research community for our next series of Research Roundtables. Based in the results of the survey below, we will schedule meetings on topics with broad interest.
All members of the research community are encouraged to participate. Please click here to quickly indicate the research topics in which you have interest.
As a grassroots organization, the BRI wants to hear from you as we set goals, create resources and prioritize efforts to best support the community. Please join us to share ideas, discuss needs, identify emerging trends and brainstorm ways to respond to them.
Click here to learn more about these roundtables and how you can benefit from them!
Congratulations to the winner of the 8th Annual BRIght Futures Prize of $100,000, Biomedical Engineer, Natalie Artzi, PhD. This project focuses on engineering therapies for better outcomes with brain cancer in children. With more than 35,000 votes from more than 110 countries and all 50 states, this year we set a record for BRIght Futures voting.
Brain tumors are the most lethal childhood cancer, with a median survival rate of only 9 to 15 months — a measure that has not changed for 20 years. Despite extensive efforts to develop better therapies, there is currently no treatment that can cure brain cancer, which specializes in escaping immune surveillance mechanisms and thus avoids immune-mediated elimination. Since a highly selective membrane protects the brain, the blood-brain barrier (BBB), whose role is to prevent most molecules from penetrating into the brain, it makes it even more challenging for drugs to reach a brain tumor. This means that even higher — and more toxic — doses of a drug may not be very effective for patients with brain cancer.
“Our solution is to deliver an adhesive patch that can reveal and kill cancer cells by (1) activating the immune system by using molecules that act as “danger” signals, and (2) delivering these molecules efficiently to the brain by using a material called an adhesive hydrogel, which can be sprayed onto and stick to the brain after surgery. This material allows us to locally release a cocktail of molecules that will activate the immune system while circumventing the BBB.”
“We plan to harness nanotechnology to form particles at a size of 1,000th the diameter of a single human hair. These nanoparticles specialize in penetrating cancer cells and may be programmed to deliver drugs at a predetermined rate. This technology will ensure that the immune system remains active and that the tumor will not come back.”
The BRIght Futures Prize will allow Dr. Artzi to take the first steps in making this therapy a reality, making the hydrogels and testing their safety and effectiveness in a preclinical model of brain cancer.
Athena Petrides, PhD and Joji Suzuki, MD were named the two winners of the McGraw Family Opioid Innovator Award. Out of the five projects pitched, Petrides and Suzuki were voted the winners, each receiving $50,000 to advance their work.
Since 2012, Brigham & Women’s Hospital has been hosting shark tanks to fund innovative and high-risk/high impact projects in the basic, clinical, digital and translational realms through its Health & Technology Innovation Awards. Sponsored by the Brigham Research Institute (BRI) and the BWH Health & Technology Subcommittee, these awards aim to advance projects that have the potential to make an impact in one or more of the following domains – biomedical research, healthcare delivery, the generation of new companies/products/services, cost savings, care quality and provider burnout. Since 2012, more than $1 million has been distributed to BWH investigators through these awards.
This year, with the generous support of the McGraw Family, this cycle’s Request for Applications includes a special track focused on advancing innovations related to solving the opioid crisis which has resulted in the loss of over 2000 lives in the past year in Massachusetts alone. Novel ideas that seek to address questions and challenges related to the opioid epidemic including, but not limited to, research on addiction, adverse effects, alternate pain management strategies, genetic susceptibility to opioid abuse, new tools for opioid research, diagnosis/treatment, management of infectious diseases related to opioid abuse, withdrawal, personalized medicine will be awarded.
DigiToxRX: Treating Pain is No Longer Painful
Interpreting urine toxicology results is a time-consuming and complex task for clinicians prescribing opioids. Approximately 500 toxicology results are misinterpreted annually at Brigham and Women’s Hospital, potentially leading to inappropriate opioid refills and discontinuation of appropriate opioid treatment. DigiToxRx offers a complete solution, which encompasses a novel testing methodology paired with software that automates personalized toxicology interpretations. Our recent study demonstrated that personalized interpretations improved clinician confidence in result review by 34% and increased the speed of review by 46%. Financial support of DigiToxRx will allow us to automate personalized interpretations and to scale this service across Partners and potentially other healthcare systems.
Pilot Study of cannabidiol (CBD) for the treatment of opioid use disorder
Research has shown that buprenorphine (suboxone) reduces the risk of overdose among individuals with opioid use disorder (OUD) by up to 70%. However, 50% of patients will leave treatment in the first 6 months, partly due to the emergence of strong cravings in response to cues. Recent animal and human studies demonstrate that cannabidiol (CBD), a non-addictive constituent of marijuana, helps to blunt the cravings that emerge after exposure to cues. Our team propose to conduct a pilot study to determine if CBD will reduce cue-induced cravings among OUD patients currently taking buprenorphine. If successful, this study will lay the groundwork for a NIH-funded study to conduct a series of human trials with CBD for OUD patients as an adjunct to buprenorphine treatment.
Peter Chai, MD, MMS, Assistant Professor, Emergency Medicine, BWH
Enabling smart sewers to measure community level opioid and naloxone consumption
Christopher W. Connor, MD, PhD, Assistant Professor, Anesthesiology, BWH
Imaging opioid effects, tolerance and addiction in C. elegans
R. Jason Yong, MD, MBA, Instructor, Anesthesiology, BWH
Smart Pill Dispenser to Enhance Opioid Compliance and Patient Outcomes
The BRI Executive Committee is opening three guest slots at each monthly Research Oversight Committee (ROC) meeting. If you wish to attend a ROC meeting, please sign up here (note that you may only attend one ROC meeting per calendar year as a guest). Feel free to email bwhbri@partners.org with questions.
The BRI’s overarching mission is to accelerate discoveries that improve human health; supporting strategies include fostering groundbreaking, interdepartmental, and interdisciplinary research, ranging from basic fundamental studies to clinical innovations. We strive to provide a clear voice (internally and externally) for the entire BWH research community, raise the profile of research at BWH, develop mission-centric collaborations with external entities and engage the scientific community in fundraising. Research Oversight Committee (ROC) members help bring forward the needs and concerns of their colleagues; accordingly, the composition of the ROC is intended to collectively reflect the diversity of the BWH research community.
Join the PostDoctoral Association from September 16 to September 20 to recognize all that our postdocs do for the research community at BWH and across the nation.
|
|
|
|
A sex- and gender-informed perspective increases rigor, promotes discovery, and expands the relevance of biomedical research. In the current era of accountability to present data for males and females, thoughtful and deliberate methodology can improve study design and inference in sex and gender differences research. We address issues of motivation, subject selection, sample size, data collection, analysis, and interpretation, considering implications for basic, clinical, and population research. In particular, we focus on methods to test sex/gender differences as effect modification or interaction, and discuss why some inferences from sex-stratified data should be viewed with caution. Without careful methodology, the pursuit of sex difference research, despite a mandate from funding agencies, will result in a literature of contradiction. However, given the historic lack of attention to sex differences, the absence of evidence for sex differences is not necessarily evidence of the absence of sex differences. Thoughtfully conceived and conducted sex and gender differences research is needed to drive scientific and therapeutic discovery for all sexes and genders.
Rich-Edwards JW, Kaiser UB, Chen GL, Manson JE, Goldstein JM. Sex and Gender Differences Research Design for Basic, Clinical, and Population Studies: Essentials for Investigators. Endocr Rev. 2018 Aug 1;39(4):424-439. Review. PubMed PMID: 29668873.
An event co-sponsored by the BRI and MassBio
Why is networking important in an academic setting? Is it necessary? Can a self-proclaimed introvert successfully network and build relationships?
This panel discussion, moderated by Frank S. David, MD, PhD, illustrated why networking is a great way to create and maintain relationships that will provide professional and educational opportunities for months and even years to come. The panelists focused on the “how” and the “why” behind networking while imparting words of wisdom to the group, each adding their own unique perspective to the conversation.
Sandro Santagata, MD, PhD pointed out that while he does not consider himself a “networker,” he understands that it is crucial to be open and collaborative. Even introverts like himself can organically create strong relationships simply through working with others and maintaining an open mind.
Elena Aikawa, MD, PhD advised the crowd to join small societies because it offers people the chance to interact and make themselves visible among a tight-knit and potentially less intimidating group. Career development, promotion, and job changes will undoubtedly call for more than one letter of support and recommendation; it is critical to have a strong band of people to connect with and be able to rely on.
Erin McKenna, MBA emphasized the beauty of networking, in that you can never predict what may come from countless random, or planned, interactions. One simple conversation over the most trivial common interest has the potential to lead to a promotion, new career path, or partnership.
Natalie Artzi, PhD stated the importance of branching out and gaining exposure in every way possible. The more you do that, the more opportunity there will be. At the same time, remember to expand your network to those outside of your specific interests, fields, and studies. Find people that can compliment your skills and help you to grow.
The panelists made it clear that everyone needs mentors and sponsors; everyone needs someone to help them get places they never thought they could. Networking is essential in creating these types of opportunities. Any conversation, any connection no matter how small, can aid in career development and help to carry you through the next steps in life. Equally as important, these relationships must be maintained, groomed, and properly cared for over an extended period. Keep in touch, invite them to your lab space, send them an email or a letter. No matter how you do it, networking cannot live on its own. Without tending to it, the bonds will weaken, and the connections, and opportunities that go along with them, will be lost as quickly as they were gained.
Social media is one way to maintain these meaningful relationships. Br. David brought Twitter and LinkedIn into the conversation. These platforms offer a way to exemplify best qualities, demonstrate hobbies outside of the office or lab, and disseminate information to a relevant audience.
Before the Q&A and networking commenced, Dr. David ended the discussion by encouraging the audience to “be the change that they want to be.” Whether you are introverted, extroverted, struggle to connect to others, or shy away from social media, make the changes that will allow you to create opportunity, build lasting relationships, and develop your ever-growing career paths.
The BWPO is pleased to announce the opening of nominations for the 2019 Faculty Pillar Awards. Faculty members in academic medical centers serve in multiple capacities as mentors, innovators, collaborators, and community leaders. This award program was established in 2013 to recognize Brigham faculty for achievement in one, or more, of the five pillars of academic medicine:
The 2019 Faculty Pillar Award recipients will be announced in August, and we will recognize all awardees at the annual New Faculty Welcome Lunch and Awards Celebration on Friday, September 13th, 2019, as well as with a publicly displayed plaque outside the BWH gift shop.
Please consider nominating a colleague, mentor, and/or leader whose accomplishments merit recognition. Note, there are two awards for non-faculty members, including a Postdoctoral Leadership Award for research fellows at HMS as well as a Contribution to Faculty Development and Diversity Award, for any BWH/BWPO employee who had made significant achievement in supporting this pillar.
Award nominations can be submitted by all faculty or other Brigham employees and will be accepted Wednesday, June 6th through Friday, July 12th.
Full 2019 award descriptions and the nomination form are available online: http://bwhcfdd.partners.org/Listing.aspx?courseId=435
If you have any questions, please contact BWPOFDW@bwh.harvard.edu
Categories for recognition
Mentorship Awards
Senior Faculty Mentor Award
Junior Faculty Mentor Award
Clinical Teacher Award
Education Awards
Educational Program Leadership Award
Educational Research Award
Research Awards
Research Collaboration Award
Research Innovation Award
Research Leadership Award
Postdoctoral Research Fellow Leadership Award
Community Service Awards
Community Service Award
Research Community Service Award
Diversity and Inclusion Awards
Diversity and Inclusion Service Award
Contribution to Faculty Development and Diversity Award